Causes of gastro intestinal bleedingBleed.ppt

ARULMURUGANL 11 views 47 slides Aug 09, 2024
Slide 1
Slide 1 of 47
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47

About This Presentation

Causes of gastro intestinal bleeding


Slide Content

Acute Gastrointestinal
Bleeding

GI Bleeding
•Clinical Presentation
•Acute Upper GI Bleed
•Acute Lower GI Bleed

Case Presentation
•CC: Melena
•HPI: 54 yo man taking ibuprofen 200 mg
po tid for the past 2 wks b/o acute LBP
after lifting presents with 2 day h/o
melena
•PMHx: neg All: NKDA SHx/FHx: neg
•Vitals: BP 105/75 P 90
•PE: normal

Clinical Presentation
Hematemesis: bloody vomitus (bright red or
coffee-grounds)
Melena: black, tarry, foul-smelling stool
Hematochezia: bright red or maroon blood
per rectum
Occult: positive guaiac test
Symptoms of anemia: angina, dyspnea, or
lightheadedness

Patient Assessment
•Hemodynamic status
•Localization of bleeding source
•CBC, PT, and T & C
•Risk factors
–Prior h/o PUD or bleeding
–Cirrhosis
–Coagulopathy
–ASA or NSAID’s

Resuscitation
•2 large bore peripheral IV’s
•Normal saline or LR
•Packed RBCs
•Correct coagulopathy

Location of Bleeding
•Upper
–Proximal to Ligament of Treitz
–Melena (100-200 cc of blood)
–Azotemia
–Nasogatric aspirate
•Lower
–Distal to Ligament of Treitz
–Hematochezia

Acute UGIB
Demographics
•10,000 - 20,000 deaths annually
•Mortality stable at 10%
•80% self-limited
•Continued or recurrent bleeding -
mortality 30-40%

•Cause of bleeding
•Severity of initial bleed
•Age of the patient
•Comorbid conditions
•Onset of bleeding during
hospitalization
Acute UGIB
Prognostic Indicators

NASOGASTRIC
ASPIRATE
STOOL
COLOR
MORTALITY RATE
(%)
Clear Red, brown, or black 10
Coffee Grounds Brown or black 10
Red 20
Red Blood Black 10
Brown 20
Red 30

Acute UGIB
Prognostic Indicators
Tedesco et al. ASGE Bleeding Survey. Gastro Endo. 1981.

Acute UGIB
Differential Diagnosis

•Peptic ulcer disease
–Gastric ulcer
–Duodenal ulcer
•Mallory-Weiss tear
•Portal hypertension
–Esophagogastric
varices
–Gastropathy
•Esophagitis
•Dieulafoy’s lesion
•Vascular anomalies
•Hemobilia
•Hemorrhagic
gastropathy
•Aortoenteric fistula
•Neoplasms
–Gastric cancer
–Kaposi’s sarcoma
Acute UGIB
Differential Diagnosis

DIAGNOSES % OF TOTAL
Duodenal ulcer 24
Gastric erosions 23
Gastric ulcer 21
Varices 10
Mallory-Weiss tear 7
Esophagitis 6
Acute UGIB
Final Diagnoses of the Cause in 2225 Patients
Tedesco et al. ASGE Bleeding Survey. Gastro Endo. 1981.

DIAGNOSES % OF TOTAL
Peptic ulcer 55
Varices 14
Angioma 6
Mallory-Weiss tear 5
Erosions 4
Tumor 4


Acute UGIB
Causes in CURE Hemostasis Studies (n=948)
Savides et al. Endoscopy 1996;28:244-8.

Acute UGIB
CORI Database
University, VA, & private
practices
20 months (12/99-7/01)
7822 EGDs for UGIB
BoonpongmaneeS. et al. Gastrointest Endosc 2004;59:788-94.

Endoscopic Appearance
of Ulcers

Prognostic Features at Endoscopy
in Acute Ulcer Bleeding
Laine and Peterson New Eng J Med 1994;331:717-27.

•Thermal
–Bipolar probe
–Monopolar probe
–Argon plasma
coagulator
–Heater probe
•Mechanical
–Hemoclips
–Band ligation
•Injection
–Epinephrine
–Alcohol
–Ethanolamine
–Polidocal
Endoscopic Therapy of PUD

Endoscopic Therapy of PUD
Laine and Peterson New Eng J Med 1994;331:717-27.

Adjuvant Medical Therapy
of PUD
•Acid suppression (intragastric pH > 4)
–Histamine 2 Receptor Antagonists (H2RAs)
•Ranitidine (Zantac)
•Famotidine (Pepcid)
–Proton Pump Inhibitors (PPIs)
•Pantoprazole (Protonix)
•Lansoprazole (Prevacid)
•Esomeprazole (Nexium)

Bleeding PUD: IV H2RAs
Meta-Analysis
•Duodenal ulcer: no
benefit
•Gastric ulcer: mild
benefit
–Mortality
•ARR 3%; NNT 33
–Surgery
•ARR 7%; NNT 14
–Rebleeding
•ARR 7%; NNT 14
•Caveats
–Tolerance develops
within 24 hrs
–More potent acid
suppression
available
Levine JE et al. Aliment Pharmacol Ther 2002;16:1137-42.

472 patients required no
endoscopic treatment
27 patients not included:
comorbid or no consent
120 patients received IV
omeprazole 80 mg bolus
then 8 mg/hr for 72 hours
120 patients received placebo
267 received endoscopic treatment
739 patients admitted with GI bleeding
Lau et al. New Eng J Med 2000;343:310-316.
Adjuvant Medical Therapy of
PUD

Adjuvant Medical
Therapy of PUD
Lau et al. New Eng J Med 2000;343:310-316.

Bleeding PUD: PO/IV PPIs
Meta-Analysis
•Reduction in:
–RebleedingNNT* 4-17
–SurgeryNNT* 6-25
•No change in mortality
•PPIs add to endoscopic
therapy but do not
supplant endoscopic
therapy
* Estimates from pooled ORs
Leontiadis, GI et al. BMJ 2005;330:568-75.

Mallory-Weiss Tear

Esophageal Varices

Variceal Band Ligation

Variceal Band Ligation

•Vasopressin/Glypressin
•Nonselective vasoconstrictor
•50% efficacy in controlling bleeding
•25% vasospastic side effects
•Octreotide
•Cyclic octapeptide analog of
somatostatin
•Longer acting than somatostatin
•Equivalent to sclerotherapy and
improves endoscopic results
MEDICAL THERAPY
Acute Variceal Bleeding

TIPS
IVC
Portal Vein
Splenic Vein
Coronary Vein

Aortoduodenal Fistula
Aorta
Duodenum
Graft
Fistula

Acute Bleeding
Changes Before and After 2 Liter Bleed
0
1
2
3
4
5
6
Before During 24-72 Hrs
V
O
L
U
M
E

(

L

)
Plasma RBC
27%
45%
45%

Acute UGIB
Surgery
•Recurrent bleeding despite
endoscopic therapy
•> 6-8 units pRBCs

Case Presentation
•CC: Hematochezia
•HPI: 74 yo woman presents with 6 hour
history of painless maroon blood per rectum
•PMHx: CAD, Chol, AFib, CABG, L-CEA
•Meds: ASA, coumadin, digoxin, lovastatin
•Vitals: BP 105/75 P 90
•PE: irreg rhythm, maroon blood on DRE

Acute LGIB
Differential Diagnosis

•Diverticulosis
•Colitis
–IBD (UC>>CD)
–Ischemia
–Infection
•Vascular anomalies
•Neoplasia
•Anorectal
–Hemorrhoids
–Fissure
•Dieulafoy’s lesion
•Varices
–Small bowel
–Rectal
•Aortoenteric fistula
•Kaposi’s sarcoma
•UPPER GI BLEED
Acute LGIB
Differential Diagnosis

DIAGNOSES % OF TOTAL
Diverticulosis 40
Vascular anomalies 30
Colitis 21
Neoplasia 14
Anorectal 10
Upper GI sites 10
Acute LGIB
Diagnoses in pts with hemodynamic compromise.
Zuccaro. ASGE Clinical Update. 1999.

Diverticulosis

Diverticular Bleeding

Urgent Colonoscopy for the Diagnosis
and Treatment of Severe Diverticular
Hemorrhage
•121 pts with severe
bleeding (>4 hrs
after hospitalization)
•1
st
73 pts: no
colonoscopic tx
•Last 48 pts eligible
for colonoscopic tx
•Colonoscopy w/in 6-
12 hrs

Urgent Colonoscopy for the Diagnosis and
Treatment of Severe Diverticular
Hemorrhage
Jensen DM, et al. New Eng J Med 2000:342:78-82.

Hemorrhoids

Bleeding AVM

Radiation Proctitis

•Incidence 0.3 - 3.0 %
•EtiologyIncomplete obliteration of the
vitelline duct.
•Pathology50% ileal, 50% gastric,
pancreatic, colonic mucosa
•Complications
–Painless bleeding (children, currant jelly)
–Intussusception
Acute LGIB
Meckel’s Diverticulum

Study
Yield
%
Comments
Colonoscopy 69-80 Therapeutic
Arteriography 40-78
1 ml/min,
risks
Tagged RBC Scan 20-72 Localization


Acute LGIB
Evaluation
Zuccaro. ASGE Clinical Update. 1999.

•Resuscitation
•UGI source
•Most bleeding ceases
•Colonscopy - early
•No role for barium studies
•5% Mortality
Acute LGIB
Key Points
Tags